111, Inc. Sponsored ADR

YI Healthcare Medical Distribution

111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.

3.09 0.00 0.00%
Market cap
$16.0M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
3.31
Beneish M
−3.28
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — 4 3 5 3 4 3 7 5
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — 0.36 0.61 1.69 2.23 2.36 2.82 3.36 3.31
P/S ratio
0.00 0.00 0.00 0.10 0.05 0.01 0.01 0.01 0.00 0.01
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 2.75
Altman Z″-Score (non-manufacturers)
4.47 (2.55) 4.38 (2.02) (0.71) (3.14) (3.08) (4.56) (4.01) (5.61)
P/Operating CF
0.00 0.00 (1.65) (4.62) (2.42) (0.58) 2.89 (0.48) (0.64) 4.95
Beneish M-Score
— (4.06) (1.81) 0.12 (1.89) (0.90) (3.17) (2.35) (3.12) (3.28)
P/B ratio
0.00 0.00 0.14 0.50 0.92 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.14 0.50 0.93 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 (0.06) (0.12) (0.04) (0.04) (0.02) (0.02) (0.02)
EV/EBITDA
0.00 0.00 0.00 0.44 2.15 0.78 1.53 0.68 0.00 112.75
EV/Operating CF
0.00 0.00 0.00 0.43 8.70 0.72 24.56 0.53 (1.21) (2.25)
EV/FCF
0.00 0.00 0.00 0.43 5.86 0.62 3.30 0.40 (2.43) (4.73)
Quick Ratio
4.28 2.39 3.61 0.99 1.09 0.63 0.52 0.44 0.40 0.45
Current Ratio
5.23 3.63 4.79 1.92 1.76 1.32 1.19 1.07 1.13 1.09
Net Debt/EBITDA
1.74 1.93 2.84 1.25 3.03 1.11 2.25 1.02 (18.74) (44.78)
Debt/Assets
0.00% 0.00% 0.00% 5.90% 7.57% 8.25% 5.15% 10.94% 5.77% 8.53%
Debt/Equity
0.00 0.00 0.00 0.12 0.56 (1.71) (0.44) (0.57) (0.24) (0.26)
Asset Turnover
0.77 0.97 1.53 2.49 3.62 4.07 3.93 4.49 4.83 5.16
Operating CF/Net income
0.93 0.82 0.90 1.03 0.26 1.03 0.06 1.14 (4.06) (1.79)
Capex/Depreciation
0.00 (0.46) (1.31) (2.09) (1.83) (2.29) (0.75) (0.38) (0.87) (0.37)
Interest Coverage
— (4,798.62) (58.23) (136.32) (53.69) (117.03) (27.60) (17.38) 0.07 (0.07)
ROE
51.65% 31.08% (313.93%) (49.64%) (80.68%) (547.31%) 145.42% 77.35% 10.20% 9.82%
ROA
(36.72%) (25.19%) (32.49%) (31.46%) (20.13%) (21.96%) (12.12%) (11.78%) (2.17%) (2.73%)
ROIC
0.00% 0.00% (213.47%) (180.08%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(58.13%) (45.50%) (31.34%) (67.71%) (35.49%) (89.07%) (74.55%) (176.42%) (19.04%) (34.53%)
Average Days of Receivables
38.23 7.76 5.84 6.03 7.26 11.88 13.20 13.11 10.47 7.55
Research and Development Expense of Revenue
6.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
43.94% 25.38% 20.09% 11.74% 6.43% 5.80% 4.91% 4.50% 2.67% 2.61%
Intangible Assets out of Total Assets
0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 1.03% 2.88% 1.37% 0.92% 1.17% 1.20% 1.52% 0.14% 0.08%
Graham Net Nets
0.00 0.00 6.84 1.68 0.68 (2.68) (3.69) (7.60) (20.48) (5.12)
Graham Number
0.00 0.00 0.00 0.00 0.00 28.79 34.41 38.41 12.29 16.33
Earnings Yield
(4.35%) (4.35%) (6.51%) (133.73%) (117.99%) (365.71%) (242.62%) (400.00%) (103.23%) (39.06%)
Free Cash Flow Yield
0.00% 0.00% 0.00% (133.63%) (46.40%) (434.90%) (98.40%) (596.26%) 336.96% 36.37%
Revenue per Share
1.61 40.28 52.24 69.37 152.58 235.11 235.21 249.74 229.63 206.35
Operating CF per Share
(0.71) (8.58) (10.03) (8.99) (2.17) (13.03) (0.40) (7.47) 4.19 1.96
Capex per Share
0.00 (0.29) (0.43) (0.43) (0.48) (1.18) (0.53) (0.14) (0.23) (0.07)
Free Cash Flow per Share
(0.71) (8.86) (10.46) (9.42) (2.65) (14.21) (0.93) (7.61) 3.96 1.89
Cash per Share
1.12 19.36 32.37 12.25 30.11 17.85 16.06 11.26 8.26 10.05
Shareholders Equity per Share
1.92 (39.66) 35.79 13.58 7.56 (2.88) (7.11) (9.94) (10.49) (11.86)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.92 (39.66) 35.79 13.58 7.56 (2.88) (7.11) (9.94) (10.49) (11.86)
Free Cash Flow
(58.50) (31.91) (52.03) (77.11) (21.83) (117.88) (7.78) (64.14) 34.01 16.41
Working Capital
104.85 79.99 173.45 101.70 190.50 105.41 74.05 26.52 42.07 24.48
Capital Expenditures
(1.04) (1.03) (2.14) (3.51) (3.93) (9.79) (4.42) (1.15) (2.02) (0.62)
Net Current Asset Value
104.85 (147.74) 172.27 92.66 38.72 (77.87) (93.76) (105.70) (109.08) (113.95)
EV/EBIT
0.00 0.00 0.00 0.44 2.15 0.78 1.53 0.68 0.00 112.72
Capex to Sales
0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18.43 0.00
Other line items
Depreciation/Fixed assets
0.52 0.87 0.56 0.39 0.32 0.34 0.84 0.63 0.52 0.56
Cash ROIC
(23.40%) 43.68% (15.35%) (34.26%) (6.32%) (71.49%) (7.74%) (109.20%) 1,173.30% 148.15%
Accounts Receivable Turnover
9.27 17.15 71.78 83.93 73.16 44.08 29.17 28.74 29.85 38.31
Accounts Payable Turnover
7.11 7.85 9.74 11.49 10.52 9.86 7.87 8.28 8.09 8.07
Inventory Turnover
5.55 6.21 9.33 10.82 12.82 12.63 9.35 9.52 9.54 10.17
Average Days of Payables
42.89 53.84 46.07 42.83 49.99 41.66 50.82 41.13 46.30 39.56
Days of Inventory on Hand
62.39 60.53 45.76 46.87 35.70 34.66 43.16 36.75 37.31 30.80
Average Receivables
14.24 8.45 3.62 6.76 17.18 44.23 67.18 73.25 66.10 46.87
Average Payables
16.89 16.73 25.12 47.35 114.16 187.96 233.65 239.82 229.80 209.61
Average Inventory
21.64 21.14 26.22 50.26 93.66 146.70 196.62 208.62 195.00 166.43
Average Assets
171.57 149.14 170.14 228.11 347.57 478.74 498.65 469.37 408.50 348.28
Average Common Equity
(121.97) (120.88) 17.61 144.58 86.73 19.20 (41.56) (71.51) (86.96) (96.67)

Fold the line items

Columns are period end dates